I. Henrı́quez

1.1k total citations
43 papers, 695 citations indexed

About

I. Henrı́quez is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, I. Henrı́quez has authored 43 papers receiving a total of 695 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Pulmonary and Respiratory Medicine, 11 papers in Radiology, Nuclear Medicine and Imaging and 7 papers in Oncology. Recurrent topics in I. Henrı́quez's work include Prostate Cancer Treatment and Research (22 papers), Prostate Cancer Diagnosis and Treatment (17 papers) and Radiopharmaceutical Chemistry and Applications (7 papers). I. Henrı́quez is often cited by papers focused on Prostate Cancer Treatment and Research (22 papers), Prostate Cancer Diagnosis and Treatment (17 papers) and Radiopharmaceutical Chemistry and Applications (7 papers). I. Henrı́quez collaborates with scholars based in Spain, United States and Belgium. I. Henrı́quez's co-authors include B. Guix, F. Finestres, C. Conill, E. Verger, Antonio Martı́nez, Oscar Abuchaibe, Felipe Couñago, Gemma Sancho, Meritxell Arenas and Alberto Bossi and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and European Journal of Cancer.

In The Last Decade

I. Henrı́quez

43 papers receiving 672 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
I. Henrı́quez Spain 14 273 175 163 131 118 43 695
Irene Karam Canada 19 272 1.0× 265 1.5× 157 1.0× 44 0.3× 98 0.8× 96 836
Nicole Hodgson Canada 16 195 0.7× 246 1.4× 318 2.0× 38 0.3× 393 3.3× 45 882
Arti Parekh United States 13 415 1.5× 281 1.6× 139 0.9× 20 0.2× 155 1.3× 19 792
Emily Sinclair Canada 20 300 1.1× 379 2.2× 519 3.2× 53 0.4× 18 0.2× 67 1.0k
Allen Hayashi Canada 17 262 1.0× 194 1.1× 577 3.5× 55 0.4× 184 1.6× 35 1.1k
Shaelyn Culleton Canada 18 244 0.9× 388 2.2× 367 2.3× 21 0.2× 29 0.2× 31 838
Marina Djurfeldt Canada 13 236 0.9× 457 2.6× 161 1.0× 21 0.2× 47 0.4× 32 1.1k
Stephen Rush United States 17 455 1.7× 390 2.2× 268 1.6× 33 0.3× 98 0.8× 51 1.3k
David Chu United States 13 171 0.6× 425 2.4× 438 2.7× 17 0.1× 50 0.4× 26 876
Heinz Haverkamp Germany 19 399 1.5× 519 3.0× 140 0.9× 20 0.2× 44 0.4× 53 1.3k

Countries citing papers authored by I. Henrı́quez

Since Specialization
Citations

This map shows the geographic impact of I. Henrı́quez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. Henrı́quez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. Henrı́quez more than expected).

Fields of papers citing papers by I. Henrı́quez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I. Henrı́quez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. Henrı́quez. The network helps show where I. Henrı́quez may publish in the future.

Co-authorship network of co-authors of I. Henrı́quez

This figure shows the co-authorship network connecting the top 25 collaborators of I. Henrı́quez. A scholar is included among the top collaborators of I. Henrı́quez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I. Henrı́quez. I. Henrı́quez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Peleteiro, Paula, I. Henrı́quez, Antonio J. Conde-Moreno, et al.. (2020). Age, Gleason Score, and PSA are important prognostic factors for survival in metastatic castration-resistant prostate cancer. Results of The Uroncor Group (Uro-Oncological Tumors) of the Spanish Society of Radiation Oncology (SEOR). Clinical & Translational Oncology. 22(8). 1378–1389. 14 indexed citations
2.
Segundo, Carmen González‐San, Josep Jové, A. Zapatero, et al.. (2019). Survival after biochemical failure in prostate cancer treated with radiotherapy: Spanish Registry of Prostate Cancer (RECAP) database outcomes. Clinical & Translational Oncology. 21(8). 1044–1051. 5 indexed citations
3.
Gómez‐Caamaño, Antonio, et al.. (2018). Consensus on management of castration-resistant prostate cancer on behalf of the Urological Tumours Working Group (URONCOR) of the Spanish Society of Radiation Oncology. Clinical & Translational Oncology. 21(4). 420–432. 5 indexed citations
4.
Hervás, A., Carlos González, Josep Jové, et al.. (2018). Outcomes and prognostic factors in intermediate-risk prostate cancer: multi-institutional analysis of the Spanish RECAP database. Clinical & Translational Oncology. 21(7). 900–909. 3 indexed citations
5.
Couñago, Felipe, et al.. (2018). Multiparametric MRI for prostate cancer: a national survey of patterns of practice among radiation oncologists in Spain. Clinical & Translational Oncology. 20(11). 1484–1491. 2 indexed citations
6.
Couñago, Felipe, Carlos Artigas, Gemma Sancho, et al.. (2018). PET/TC con 68Ga-PSMA, importancia en la práctica hospitalaria. Visión del oncólogo radioterápico. Revista Española de Medicina Nuclear e Imagen Molecular. 37(5). 302–314. 6 indexed citations
7.
Couñago, Felipe, Carlos Artigas, Gemma Sancho, et al.. (2018). Importance of 68Ga-PSMA PET/CT in hospital practice. View of the radiation oncologist. Revista Española de Medicina Nuclear e Imagen Molecular (English Edition). 37(5). 302–314. 9 indexed citations
8.
Henrı́quez, I., A. Rodrı́guez-Antolı́n, Javier Cassinello, et al.. (2017). Consensus statement on definition, diagnosis, and management of high-risk prostate cancer patients on behalf of the Spanish Groups of Uro-Oncology Societies URONCOR, GUO, and SOGUG. Clinical & Translational Oncology. 20(3). 392–401. 1 indexed citations
9.
Henrı́quez, I., David Parada, Pablo Gallardo, et al.. (2017). Prognostic correlation of cell cycle progression score and Ki-67 as a predictor of aggressiveness, biochemical failure, and mortality in men with high-risk prostate cancer treated with external beam radiation therapy. Reports of Practical Oncology & Radiotherapy. 22(3). 251–257. 4 indexed citations
10.
Casas, Francesc, I. Henrı́quez, Xavier Maldonado, et al.. (2016). Intermittent versus continuous androgen deprivation therapy to biochemical recurrence after external beam radiotherapy: a phase 3 GICOR study. Clinical & Translational Oncology. 19(3). 373–378. 5 indexed citations
11.
Gómez‐Iturriaga, Alfonso, Alejandro Pérez Cabeza, Josep Jové, et al.. (2016). The number of risk factors is the strongest predictor of prostate cancer mortality: multi-institutional outcomes of an extreme-risk prostate cancer cohort. Clinical & Translational Oncology. 18(10). 1026–1033. 3 indexed citations
12.
Arenas, Meritxell, I. Henrı́quez, M. Murcia, et al.. (2015). Hypofractionated high-dose-rate plesiotherapy in nonmelanoma skin cancer treatment. Brachytherapy. 14(6). 859–865. 35 indexed citations
13.
Henrı́quez, I., Gemma Sancho, A. Hervás, et al.. (2014). Salvage brachytherapy in prostate local recurrence after radiation therapy: predicting factors for control and toxicity. Radiation Oncology. 9(1). 102–102. 44 indexed citations
14.
Arenas, Meritxell, S. Sabater, I. Henrı́quez, et al.. (2014). Quality assurance in radiotherapy: analysis of the causes of not starting or early radiotherapy withdrawal. Radiation Oncology. 9(1). 260–260. 20 indexed citations
15.
Henrı́quez, I., et al.. (2014). Needle track recurrence after transrectal prostate biopsy detected by 18F-Choline PET–CT. Revista Española de Medicina Nuclear e Imagen Molecular. 34(2). 128–129. 2 indexed citations
16.
17.
Conill, C., et al.. (1997). Symptom prevalence in the last week of life. Journal of Pain and Symptom Management. 14(6). 328–331. 148 indexed citations
18.
Martín‐Algarra, Salvador, et al.. (1990). Severe polyneuropathy and motor loss after intrathecal thiotepa combination chemotherapy. Anti-Cancer Drugs. 1(1). 33–36. 7 indexed citations
19.
Calvo, Felipe A., et al.. (1989). Postoperative radical radiotherapy with concurrent weekly intra-arterial cis-platinum for treatment of malignant glioma: a pilot study. Radiotherapy and Oncology. 14(2). 83–88. 13 indexed citations
20.
Calvo, Felipe A., et al.. (1989). Intraoperative and external beam radiotherapy in advanced resectable gastric cancer: Technical description and preliminary results. International Journal of Radiation Oncology*Biology*Physics. 17(1). 183–189. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Irene Karam Breakdown of academic impact, for papers by Nicole Hodgson Breakdown of academic impact, for papers by Arti Parekh Breakdown of academic impact, for papers by Emily Sinclair Breakdown of academic impact, for papers by Allen Hayashi Breakdown of academic impact, for papers by Shaelyn Culleton Breakdown of academic impact, for papers by Marina Djurfeldt Breakdown of academic impact, for papers by Stephen Rush Breakdown of academic impact, for papers by David Chu Breakdown of academic impact, for papers by Heinz Haverkamp
Rankless by CCL
2026